Platinum Sensitive Recurrent Ovarian Cancer Last updated on Oct 28, 2024 Previous OCEANS Trial: Bevacizumab Maintenance in Platinum Sensitive Recurrence Next AURELIA Trial: Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer
